Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture
June 23rd, 2020
11.4K views
The presented approach simultaneously evaluates cancer cell invasion in 3D spheroid assays and T-cell cytotoxicity. Spheroids are generated in a scaffold-free agarose multi-microwell cast. Co-culture and embedding in type I collagen matrix are performed within the same device which allows to monitor cancer cell invasion and T-cell mediated cytotoxicity.
Overview
This study presents a novel approach to evaluate cancer cell invasion and T-cell cytotoxicity using 3D spheroid assays. The method allows for simultaneous monitoring of these processes within a single device, enhancing the efficiency of experimental workflows.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Cancer Research
Background
- 3D spheroid models are crucial for studying tumor behavior.
- Understanding T-cell mediated cytotoxicity is essential for cancer immunotherapy.
- Traditional methods often require multiple transfers of spheroids, complicating experiments.
- This study introduces a scaffold-free agarose multi-microwell cast for spheroid generation.
Purpose of Study
- To develop a co-culture model that simplifies the evaluation of cancer cell invasion.
- To assess T-cell cytotoxicity in a 3D environment.
- To provide mechanistic insights into immune cell interactions with tumor cells.
Methods Used
- Generation of spheroids in a scaffold-free agarose multi-microwell cast.
- Embedding spheroids in a type I collagen matrix.
- Co-culture of cancer cells and T-cells within the same device.
- Monitoring of invasion and cytotoxicity in real-time.
Main Results
- The 3D spheroid model allows for efficient evaluation of cancer cell behavior.
- Simultaneous monitoring of T-cell activity enhances experimental accuracy.
- This method eliminates the need for multiple transfers of spheroids.
- Insights gained could inform future cancer immunotherapy strategies.
Conclusions
- The presented technique is a valuable tool for cancer research.
- It facilitates a better understanding of immune-tumor interactions.
- This approach could streamline experimental workflows in related studies.
Frequently Asked Questions
What are 3D spheroids?
3D spheroids are clusters of cells that mimic the architecture and functionality of tumors in vivo.
Why is T-cell cytotoxicity important?
T-cell cytotoxicity is crucial for the effectiveness of cancer immunotherapies, as it determines how well immune cells can eliminate tumor cells.
What is the advantage of using a scaffold-free model?
Scaffold-free models simplify the experimental process by eliminating the need for transferring spheroids, reducing potential damage and variability.
How are spheroids generated in this study?
Spheroids are generated by adding molten agarose into a microwell mold, allowing them to solidify and form individual spheroids.
What is the significance of using a collagen matrix?
Embedding spheroids in a collagen matrix provides a more physiologically relevant environment for studying cell behavior.
Who demonstrated the procedure in this study?
The procedure was demonstrated by Apsra Nasir, a PhD student from the department.
Executive Industry Relevance
Simultaneous monitoring of cancer cell invasion and T-cell cytotoxicity in 3D co-culture directly addresses the need for predictive, mechanistically informative assays in immuno-oncology discovery. This integrated platform enables functional target validation and de-risking of immune-tumor interactions, supporting translational continuity from early discovery through preclinical evaluation. The approach enhances portfolio decision-making by providing quantitative, physiologically relevant data on immune-mediated tumor cell killing and invasion dynamics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic interrogation of immune cell-mediated tumor cytotoxicity in a 3D context.
- Supports functional validation of immunotherapy targets by quantifying T-cell impact on tumor spheroids.
- Facilitates biological de-risking by modeling invasive growth phenotypes relevant to human tumors.
- Provides predictive confidence for advancing immune-modulating agents.
Screening & Assay Development
- Delivers a standardized, reproducible 3D co-culture system for high-content screening of immune-tumor interactions.
- Generates quantitative invasion and cytotoxicity readouts suitable for comparative compound evaluation.
- Enables multiplexed analysis of cell behavior, marker expression, and spatial relationships via IF and IHC.
- Reduces workflow complexity by eliminating the need for spheroid transfer between assay steps.
Translational & Preclinical Research
- Aligns with disease-relevant models by recapitulating tumor microenvironment and immune infiltration.
- Supports translational biomarker discovery through spatial and phenotypic analysis of immune-tumor interactions.
- Enables risk-adjusted advancement of immunotherapeutic candidates based on functional 3D data.
- Facilitates adaptation to patient-derived samples and diverse stromal or immune cell types.
Pipeline & Workflow Integration
This 3D co-culture assay bridges early discovery, screening, and translational research by providing a unified platform for functional immune-tumor interrogation.
- Discovery Biology: Supports hypothesis testing on immune-mediated cytotoxicity and invasion mechanisms in a physiologically relevant system.
- Screening: Offers reproducible, quantitative outputs for compound or biologic evaluation in immune-oncology pipelines.
- Analytics: Enables image-based quantification of invasion, cytotoxicity, and spatial cell relationships using IF, IHC, and confocal microscopy.
- Translational Research: Provides continuity for biomarker alignment and patient sample analysis in preclinical studies.
- Enterprise Reuse: Adaptable to various tumor, immune, and stromal cell types, supporting broad portfolio applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune-oncology target validation.
- Operational Value: Streamlines workflows with integrated, transfer-free 3D co-culture and multiplexed analysis capabilities.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing robust, translationally relevant data.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of immunotherapeutic assets.
Implementation Considerations
- Requires expertise in 3D cell culture, immunofluorescence, and confocal imaging.
- Needs access to agarose microwell casting, type I collagen, and advanced imaging platforms.
- Demands cross-team standardization for reproducible assay setup and analysis.
- Adaptable to different tumor, immune, and stromal cell sources as supported by the protocol.
- Throughput and scalability depend on available instrumentation and analytical resources.
Biopharma FAQs
Why does null hypothesis testing matter for 3D invasion assays?
Null hypothesis testing in 3D invasion and cytotoxicity assays enables objective evaluation of immune cell effects on tumor spheroids, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit the co-culture workflow?
Isolating variables such as T-cell presence or ECM composition within the 3D co-culture system allows mechanistic dissection of immune-tumor interactions, informing pathway analysis and therapeutic hypothesis testing.
What do quantitative invasion and cytotoxicity measurements enable?
Quantitative readouts of invasion and cytotoxicity provide actionable data for comparing immune cell efficacy, compound activity, and tumor cell phenotypes, directly informing screening and lead prioritization.
Why are replication requirements critical for cross-functional teams?
Replication of 3D co-culture assays ensures reproducibility and reliability of results, facilitating data integration across discovery, screening, and translational research teams for portfolio decision-making.
What statistical analysis is required before implementing 3D co-culture data?
Statistical analysis of invasion and cytotoxicity outputs, including significance testing and variance assessment, is essential to validate findings and support advancement decisions in immuno-oncology pipelines.
